Craig Millian

Craig Millian

Chief Executive Officer presso HLS THERAPEUTICS INC.

Patrimonio netto: 64 616 $ in data 31/03/2024

56 anni
Health Technology
Consumer Services

Profilo

Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/02/2023 900 ( 0.01% ) 35 316 $ 31/03/2024
16/11/2023 10 000 ( 0.03% ) 29 300 $ 31/03/2024

Posizioni attive di Craig Millian

SocietàPosizioneInizio
HLS THERAPEUTICS INC. Chief Executive Officer 01/05/2023
Tutte le posizioni attive di Craig Millian

Precedenti posizioni note di Craig Millian

SocietàPosizioneFine
CORBUS PHARMACEUTICALS HOLDINGS, INC. Chief Operating Officer 14/04/2023
Corporate Officer/Principal 01/12/2018
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Craig Millian

Formazione di Craig Millian

University of Pennsylvania Undergraduate Degree
New York University Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Craig Millian

Relazioni

65

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Health Technology

HLS THERAPEUTICS INC.

Health Technology

Aziende private1

Health Technology

Vedi le connessioni aziendali